A Multicenter Study to Evaluate a Risk-adapted Strategy for Treatment of Extra Cranial Non Seminomateous Malignant Germ Cell Tumour in Children and Adolescent

NCT02104986 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

117

Enrollment

OTHER

Sponsor class

Conditions

Extra Cranial Non Seminomateous Malignant Germ Cell Tumour

Interventions

DRUG: Velbe-Bleomycin-Cisplatin
DRUG: Vepeside-ifosfamide-Cisplatin

Sponsor

Centre Leon Berard